ADMA BIOLOGICS INC (ADMA) Stock Income Statement
NASDAQ:ADMA • US0008991046
Current stock price
15.15 USD
+0.16 (+1.07%)
At close:
15.1063 USD
-0.04 (-0.29%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 510.17M | 426.45M | 258.21M | 154.10M | 80.90M | |||
| Cost Of Goods | 217.41M | 206.90M | 167.17M | 118.80M | 79.80M | |||
| Gross Profit | 292.76M | 219.55M | 91.04M | 35.30M | 1.20M | |||
| Operating Expenses | 101.32M | 80.57M | 66.64M | 74.60M | 59.50M | |||
| Research and Development | 4.76M | 1.81M | 3.30M | 3.60M | 3.60M | |||
| Selling, General, and Administrative Expenses | 96.42M | 78.37M | 62.62M | 70.30M | 55.20M | |||
| Operating Income | 191.44M | 138.98M | 24.40M | -39.30M | -58.40M | |||
| Interest Income/Expense | -5.24M | -11.83M | -23.41M | -19.20M | -13.00M | |||
| Other Income/Expense | -212.00K | -193.00K | -287.00K | -600.00K | -300.00K | |||
| Non Recurring Items | -3.34M | -1.24M | -28.94M | -6.70M | 0.00 | |||
| Income Before Taxes | 182.66M | 125.71M | -28.24M | -65.90M | -71.60M | |||
| Income Tax | 35.73M | -71.96M | N/A | N/A | N/A | |||
| Net Income | 146.93M | 197.67M | -28.24M | -65.90M | -71.60M | |||
| EBITDA | 199.54M | 147.03M | 32.73M | -32.19M | -52.90M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.60 | 0.81 | -0.13 | -0.33 | -0.51 | |||
| Non GAAP EPS | 0.60 | 0.50 | -0.13 | -0.31 | -0.52 | |||
| Statistics | ||||||||
| Gross Profit Margin | 57.39% | 51.48% | 35.26% | 22.91% | 1.48% | |||
| Profit Margin | 28.80% | 46.35% | -10.94% | -42.76% | -88.50% | |||
| Operating Profit Margin | 37.53% | 32.59% | 9.45% | -25.50% | -72.19% | |||
All data in USD